Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01648244 · ClinicalTrials.gov registry record · NA

The Use of a Computer Program to Help Primary Care Providers Treat Patients With Type 2 Diabetes

A NA study of Type II Diabetes Mellitus, sponsored by Walter Reed National Military Medical Center.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT01648244: Completed NA study of Type II Diabetes Mellitus, sponsored by Walter Reed National Military Medical Center.

NCT01648244 is a NA study of Type II Diabetes Mellitus that has completed, run by Walter Reed National Military Medical Center. The registered enrollment target is 28 participants, below the 170-participant average among 7 other Type II Diabetes Mellitus trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01648244, a NA study of Type II Diabetes Mellitus, has completed, sponsored by Walter Reed National Military Medical Center.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this study is to determine whether the use of CADS by primary care providers (PCPs) for their patients with type 2 diabetes (T2DM) changes the quality of care relative to a "usual care" group in terms of objective outcome measures of glycemic control (e.g., A1c, mean blood glucose, frequency of hypoglycemic episodes) and in terms of subjective ratings by patients.

Primary Outcome

Change is A1c will be measured 5 times over the course of the study to compare the patients for whom the provider is using CADS to those patients whose providers are delivering "usual care".

Conditions Studied

Interventions

  • OTHER Computer-Assisted Decision Support

Study Locations (1)

Maryland

  • Walter Reed National Military Medical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2012-03
Est. Completion 2015-03
Phase NA

What the finished NCT01648244 record still lists

NCT01648244 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 170-participant average among 7 other Type II Diabetes Mellitus trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Type II Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Computer-Assisted Decision Support is the first listed.

NCT01648244 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT01648244 about?

NCT01648244 is a clinical study titled "The Use of a Computer Program to Help Primary Care Providers Treat Patients With Type 2 Diabetes". The primary purpose of this study is to determine whether the use of CADS by primary care providers (PCPs) for their patients with type 2 diabetes (T2DM) changes the quality of care relative to a "usual care" group in terms of objective outcome measures of glycemic control (e.g., A1c, mean blood glu...

What is the current status of trial NCT01648244?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2012-03. Estimated completion is 2015-03.

What conditions does trial NCT01648244 study?

This clinical trial studies the following conditions: Type II Diabetes Mellitus.

What interventions are being tested in trial NCT01648244?

The interventions under investigation include: Computer-Assisted Decision Support (OTHER).

Who is sponsoring clinical trial NCT01648244?

This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01648244 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type II Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01648244, the US trial registry maintained by the National Library of Medicine. NCT01648244 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.